Todd Pendleton - 28 Feb 2024 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Mar 2024, 16:30:09 UTC
Prior SEC filing
19 Dec 2023
Next SEC filing
18 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Todd Pendleton

Key filing fact

Todd Pendleton filed Form 4 for Dolby Laboratories, Inc. (DLB) on 01 Mar 2024.

Key facts

  • This page summarizes Todd Pendleton's Form 4 filing for Dolby Laboratories, Inc. (DLB).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 01 Mar 2024, 16:30.

Change

  • Previous filing in this sequence was filed on 19 Dec 2023.
  • Current net transaction value: -$1,147,801.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DLB transaction

Class A Common Stock

Options Exercise

Transaction value
$604,024
Shares
+8,499
Change %
+18%
Price
$71.07
Shares after
56,566
Date
28 Feb 2024
Ownership
Direct
Footnotes
F1
DLB transaction

Class A Common Stock

Options Exercise

Transaction value
$240,973
Shares
+3,523
Change %
+6.2%
Price
$68.40
Shares after
60,089
Date
28 Feb 2024
Ownership
Direct
Footnotes
F1
DLB transaction

Class A Common Stock

Sale

Transaction value
$1,992,798
Shares
-24,395
Change %
-41%
Price
$81.69
Shares after
35,694
Date
28 Feb 2024
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DLB transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-8,499
Change %
-29%
Price
$0.000000
Shares after
20,644
Date
28 Feb 2024
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
8,499
Exercise price
$71.07
Footnotes
F3
DLB transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-3,523
Change %
-100%
Price
$0.000000*
Shares after
0
Date
28 Feb 2024
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
3,523
Exercise price
$68.40
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Shares held following the reported transactions include 35,694 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

Footnote F2

The shares were sold in multiple transactions at prices ranging from $81.65 to $81.78, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Footnote F3

This option was granted for a total of 29,143 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter.

Footnote F4

This option was granted for a total of 42,275 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .